{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:15:13Z","timestamp":1762521313693,"version":"build-2065373602"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T00:00:00Z","timestamp":1636761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NCT03134196"],"award-info":[{"award-number":["NCT03134196"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["U10 EY 026869"],"award-info":[{"award-number":["U10 EY 026869"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.conctc.2021.100875","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T02:10:15Z","timestamp":1637028615000},"page":"100875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Meeting the challenges of retention and enrollment of study participants in clinical trials during the COVID-19 pandemic from the study leadership perspective: Experience from the Zoster Eye Disease Study (ZEDS)"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7072-6243","authenticated-orcid":false,"given":"MeeLee","family":"Tom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9092-1203","authenticated-orcid":false,"given":"Elisabeth J.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2927-0875","authenticated-orcid":false,"given":"Carlos","family":"LopezJimenez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5889-5981","authenticated-orcid":false,"given":"Judith S.","family":"Hochman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea B.","family":"Troxel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bennie H.","family":"Jeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.conctc.2021.100875_bib1","article-title":"The zoster eye disease study (ZEDS): rationale and design","author":"Cohen","year":"2021","journal-title":"Cornea"},{"issue":"13","key":"10.1016\/j.conctc.2021.100875_bib2","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1158\/1078-0432.CCR-20-1364","article-title":"Adapting to a pandemic - conducting oncology trials during the SARS-CoV-2 pandemic","volume":"26","author":"Tan","year":"2020","journal-title":"Clin. Cancer Res. : J. Am. Assoc. Cancer Res."},{"issue":"7","key":"10.1016\/j.conctc.2021.100875_bib3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1200\/OP.20.00275","article-title":"Early impact of COVID-19 on the conduct of oncology clinical trials and long-term opportunities for transformation: findings from an American society of clinical oncology survey","volume":"16","author":"Waterhouse","year":"2020","journal-title":"JCO Oncol. Pract."},{"issue":"1","key":"10.1016\/j.conctc.2021.100875_bib4","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1186\/s13063-020-04711-6","article-title":"It is unprecedented: trial management during the COVID-19 pandemic and beyond","volume":"21","author":"Mitchell","year":"2020","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.conctc.2021.100875_bib5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13063-020-05004-8","article-title":"Managing clinical trials during COVID-19: experience from a clinical research facility","volume":"22","author":"Shiely","year":"2021","journal-title":"Trials"},{"year":"2020","series-title":"Guidance for NIH-Funded Clinical Trials and Human Subjects Studies Affected by COVID-19","author":"NIH","key":"10.1016\/j.conctc.2021.100875_bib6"}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865421001757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865421001757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:07:16Z","timestamp":1762520836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865421001757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":6,"alternative-id":["S2451865421001757"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2021.100875","relation":{},"ISSN":["2451-8654"],"issn-type":[{"type":"print","value":"2451-8654"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meeting the challenges of retention and enrollment of study participants in clinical trials during the COVID-19 pandemic from the study leadership perspective: Experience from the Zoster Eye Disease Study (ZEDS)","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2021.100875","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100875"}}